Chinese pharmaceutical companies wade Analysis of the generics market.docVIP

 PAGE \* MERGEFORMAT 9 Chinese pharmaceutical companies wade Analysis of the generics market The forefront of the world economy is gradually swells to dock China. Every industry and enterprise will inevitably be affected by this wave, pharmaceutical manufacturing industry is no exception. Patent dispute over drugs and generic drugs and this is precisely one of the most interesting scene. China’s current pattern of drug structure is: the market more than 95% of the drugs are generic drugs. By this time, China’s pharmaceutical companies have joined the patent application to register the fake drugs to a climax. The opportunities and risks coexist, the outcome, we are unable to judge. But, ‘to succeed in the day, Man proposes, God’, any prior analysis is not without benefit. An atmosphere - a step by step driven a China Opportunities Opportunity 1: a powerful pharmaceutical companies in developed countries the independence of each of the original drug research and development expenses of approximately 30 million -1.6 million U.S. dollars, a huge expenditure of the request must be reasonable to protect its rights, including the real economic benefits. However, based on the basic principles of human health, such protection is not without limitations. According to statistics, from 2002 to 2007 period, will have 30 kinds in the world pharmaceutical industry occupies a pivotal position in the drug exclusivity period has expired. Including AstraZeneca’s omeprazole (anti-ulcer drugs), Abbott’s clarithromycin (antibiotics), GlaxoSmithKline of amoxicillin (antibiotic), as well as Pfizer’s azithromycin (antibiotic), and many have been successfully used in clinical and creating a huge economic species. This opportunity is not self-evident. Opportunity 2: ‘three-line, must be my teacher’, the Chinese people since ancient times to learn the advanced experience of stress. In the field of generic drugs, we should carefully look at our neighbors, also a large population and de